PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits

• Published in: Acta biomaterialia Vol. 9; no. 5; pp. 6711 - 6722
• Main Authors: Chen, S.-H., Lei, M., Xie, X.-H., Zheng, L.-Z., Yao, D., Wang, X.-L., Li, W., Zhao, Z., Kong, A., Xiao, D.-M., Wang, D.-P., Pan, X.-H., Wang, Y.-X., Qin, L.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2013
• Subjects: Angiogenesis; Animals; bioactive properties; Biocompatibility; Biomedical materials; Bone and Bones - drug effects; Bone defect; Bone Density; Bone Development; Bone scaffold; Bones; Calcium Phosphates - chemistry; computed tomography; Defects; Flavonoids - administration & dosage; Flavonoids - pharmacology; Icaritin; Lactic Acid - chemistry; Magnetic Resonance Imaging; mineralization; orthopedics; Osteogenesis; Polyglycolic Acid - chemistry; Rabbits; Repair; Scaffolds; TCP (protocol); Tissue Scaffolds; Tomography, X-Ray Computed; tricalcium phosphate; X-radiation; Angiogenesis; Bone defect; Bone scaffold; Osteogenesis; Icaritin
• ISSN: 1742-7061; 1878-7568
• DOI: 10.1016/j.actbio.2013.01.024

Bone defect repair is challenging in orthopaedic clinics. For treatment of large bone defects, bone grafting remains the method of choice for the majority of surgeons, as it fills spaces and provides support to enhance biological bone repair. As therapeutic agents are desirable for enhancing bone healing, this study was designed to develop such a bioactive composite scaffold (PLGA/TCP/ICT) made of polylactide-co-glycolide (PLGA) and tricalcium phosphate (TCP) as a basic carrier, incorporating a phytomolecule icaritin (ICT), i.e., a novel osteogenic exogenous growth factor. PLGA/TCP/ICT scaffolds were fabricated as PLGA/TCP (control group) and PLGA/TCP in tandem with low/mid/high-dose ICT (LICT/MICT/HICT groups, respectively). To evaluate the in vivo osteogenic and angiogenic potentials of these bioactive scaffolds with slow release of osteogenic ICT, the authors established a 12mm ulnar bone defect model in rabbits. X-ray and high-resolution peripheral quantitative computed tomography results at weeks 2, 4 and 8 post-surgery showed more newly formed bone within bone defects implanted with PLGA/TCP/ICT scaffolds, especially PLGA/TCP/MICT scaffold. Histological results at weeks 4 and 8 also demonstrated more newly mineralized bone in PLGA/TCP/ICT groups, especially in the PLGA/TCP/MICT group, with correspondingly more new vessel ingrowth. These findings may form a good foundation for potential clinical validation of this innovative bioactive scaffold incorporated with the proper amount of osteopromotive phytomolecule ICT as a ready product for clinical applications.